Memantine Augmentation in Obsessive-Compulsive Disorder
Trial ID or NCT#
NCT00264238
Status
NOT RECRUITING
Purpose
The purpose of this study is to determine whether memantine is safe and effective when used as an augmentation to standard treatment for Obsessive-Compulsive Disorder (OCD).
Official Title
An Open-Label Trial of Memantine to Augment Response in the Treatment of Obsessive-Compulsive Disorder
Eligibility Criteria
Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes
Inclusion Criteria:
- * at least 18 years of age* suffering from OCD* Y-BOCS score of 18 or greater* taking a therapeutic dose of an anti-OCD medication specified in the protocol
Exclusion Criteria:
- * diagnosed with a mental disorder other than OCD* taking tiagabine or pregabalin* having had a previous trial of memantine* receiving therapy for OCD* substance abuse in the last 6 months* personality disorders sufficiently severe to interfere with study participation
Investigator(s)
JohnÌýBarry, MD
Psychiatrist
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology - Adult), Emeritus
Contact us to find out if this trial is right for you.
Contact
Nona Gamel
6507238601
View on